Development of cell-free protein synthesis platforms for discovery and/or production of biologicals[E8]

Aus der Bekanntmachung

Call: Cluster 1 - Health (Single stage - 2027/1). Type of action: HORIZON Research and Innovation Actions. Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Maintaining an innovative, sustainable, and competitive EU health industry”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes: Biopharmaceutical industries get access to streamlined development and production processes for peptide- or protein-based biologicals. Health systems benefit from the availability of enhanced or decentralised production systems for innovative health technologies that involve peptides or proteins, and which improve health and care. Citizens and patients will benefit from better access, availability and affordability of pharmaceuticals based on biologicals. Scope: Cell-Free Protein Synthesis (CFPS) has been employed in fundamental biological research for decades, however, interest for the approach as a viable means for drug development and production has only emerged in recent years. The advantages that CFPS provides in terms of efficiency, simplicity, flexibility, cost- and time savings outweigh the hurdles that are still to be overcome for CFPS to become a routine manufacturing system for peptide- or protein-based biologicals. Currently, there are several CFPS systems used that are either based on prokaryotic or eukaryotic cell lysates (including mammalian) or fully synthetic systems consi…[E3]

Die Angaben der Bekanntmachung werden so gezeigt, wie die Quelle sie veröffentlicht hat. Die Fakten und Anforderungen, die wir herausziehen, sind auf Englisch.

• Offen fürUniversities and research. Von SLETOR anhand der Wörter der Ausschreibung zugeordnet.
• BedingungEU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.[E4]

• RisikoThis is a grant, not a contract. Grants usually need a proposal against the funder's criteria, may need partners and often need co-funding.[E5]
• UnbekanntWe read the funder's listing, not the full guidance or application forms.

1. Für Angebote geöffnet · 29. Okt. 2026, 07:41 UTC

   The funder published the call with a future closing date.

   Geändert: status, notice type, published at (Quelldatensatz Development of cell-free protein synthesis platforms for discovery and/or produ… (ID HORIZON-HLTH-2027-01-IND-01))

2. Erstmals gesehen · 28. Okt. 2026, 21:22 UTC

   The funder announced the call. Applications have not opened yet.

   Quelldatensatz: Development of cell-free protein synthesis platforms for discovery and/or produ… (ID HORIZON-HLTH-2027-01-IND-01)

Jede Angabe auf dieser Seite stammt aus der Ausschreibung des Fördergebers. Jeder Eintrag zeigt den Datensatz und das Feld, aus dem er gelesen wurde.

1. E1

   The funder is European Commission.

   Aus Development of cell-free protein synthesis platforms for discovery and/or produ… (ID HORIZON-HLTH-2027-01-IND-01), Feld /metadata/type/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle ↗ (öffnet in neuem Tab)

2. E2

   Proposals must be submitted by 17 Feb 2027, 01:00 Central European time (UTC+1).

   “2027-02-17T00:00:00.000+0000”

   Aus Development of cell-free protein synthesis platforms for discovery and/or produ… (ID HORIZON-HLTH-2027-01-IND-01), Feld /metadata/deadlineDate/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle ↗ (öffnet in neuem Tab)

3. E3

   The buyer describes the requirement in the notice.

   “Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Maintaining an innovative, sustainable, and competitive EU health industry”. To that end, proposals under this topic should aim to deli…”

   Aus Development of cell-free protein synthesis platforms for discovery and/or produ… (ID HORIZON-HLTH-2027-01-IND-01), Feld /metadata/descriptionByte/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle ↗ (öffnet in neuem Tab)

4. E4

   EU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.

   “EU call topic”

   Aus Development of cell-free protein synthesis platforms for discovery and/or produ… (ID HORIZON-HLTH-2027-01-IND-01), Feld /metadata/type/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle ↗ (öffnet in neuem Tab)

5. E5

   This is an EU call for proposals.

   “31094502”

   Aus Development of cell-free protein synthesis platforms for discovery and/or produ… (ID HORIZON-HLTH-2027-01-IND-01), Feld /metadata/status/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle ↗ (öffnet in neuem Tab)

6. E6

   Applications open on 29 Oct 2026.

   “2026-10-29T00:00:00.000+0000”

   Aus Development of cell-free protein synthesis platforms for discovery and/or produ… (ID HORIZON-HLTH-2027-01-IND-01), Feld /metadata/startDate/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle ↗ (öffnet in neuem Tab)

7. E7

   The Funding & Tenders Portal gives the status as open for submission.

   Aus Development of cell-free protein synthesis platforms for discovery and/or produ… (ID HORIZON-HLTH-2027-01-IND-01), Feld /metadata/status/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle ↗ (öffnet in neuem Tab)

8. E8

   The notice is titled "Development of cell-free protein synthesis platforms for discovery and/or production of biologicals".

   Aus Development of cell-free protein synthesis platforms for discovery and/or produ… (ID HORIZON-HLTH-2027-01-IND-01), Feld /metadata/title/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle ↗ (öffnet in neuem Tab)

9. E9

   The EU contribution per grant is up to EUR 11,000,000 (from EUR 3,000,000).

   Aus Development of cell-free protein synthesis platforms for discovery and/or produ… (ID HORIZON-HLTH-2027-01-IND-01), Feld /metadata/budgetOverview/0, gelesen 29. Okt. 2026, 07:41 UTC · Quelle ↗ (öffnet in neuem Tab)

Source: EU Funding & Tenders Portal, © European Union, CC BY 4.0. SLETOR shortened and reformatted the text. Datenlizenz: Creative Commons Attribution 4.0 (European Commission) ↗ (öffnet in neuem Tab). Persönliche Kontaktdaten aus Bekanntmachungen werden weder gespeichert noch angezeigt.